Accredited Investors’s Palantir PLTR Stock Holding History

Accredited Investors’s Portfolio PLTR Stock Details PLTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-2,705	Closed	-$396K	–	309
2026 Q1	$396K	Sell	2,705 -849	-24%	-$130K	0.02%	178
2025 Q4	$632K	Buy	3,554 +469	+15%	+$84.9K	0.03%	143
2025 Q3	$563K	Buy	3,085 +116	+4%	+$18.8K	0.03%	139
2025 Q2	$405K	Buy	2,969 +115	+4%	+$13.5K	0.02%	152
2025 Q1	$241K	Sell	2,854 -69	-2%	-$6.06K	0.02%	207
2024 Q4	$221K	Buy	+2,923	New	+$170K	0.01%	209

Other funds holding PLTR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Accredited Investors's PLTR Position: Q2 2026 in Review

Accredited Investors sold out of Palantir (PLTR) in Q2 2026, closing a stake of 2,705 shares — an estimated $396K sold.

Accredited Investors first reported a position in PLTR in Q4 2024 and held it in 6 quarters. The position peaked at $632K in Q4 2025. 2,838 funds tracked by Wall St. Rank hold PLTR as of Q2 2026.

Accredited Investors reported no remaining Palantir position as of Q2 2026 after selling out during the quarter.
Accredited Investors sold 2,705 Palantir shares in Q2 2026, an estimated $396K.
Accredited Investors first reported a position in Palantir in Q4 2024 and held it in 6 quarters.
Accredited Investors's Palantir position peaked at $632K in Q4 2025.
2,838 funds tracked by Wall St. Rank held Palantir as of Q2 2026.

Based on Accredited Investors's 13F filing for Q2 2026, filed 21 Jul 2026.